DURYSTA
LIVE

Serial Number

88345288

Owner

Allergan, Inc.

First Use Date

Jan 6, 2020

Filing Date

Mar 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

DURYSTA Trademark

Serial Number: 88345288 • Registration: 6364928

DURYSTA is a trademark filed by Allergan, Inc. on March 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Allergan, Inc.

1 N. Waukegan Road
North Chicago, IL 60064

Entity Type: 03

Trademark Details

Filing Date

March 18, 2019

Registration Date

May 25, 2021

First Use Anywhere

January 6, 2020

First Use in Commerce

June 21, 2020

Published for Opposition

January 26, 2021

Goods & Services

Pharmaceutical preparations for the treatment of glaucoma

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 25, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
May 25, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 21, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 20, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 10, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 9, 2021 AITU
USE AMENDMENT FILED
Mar 24, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 24, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 23, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 26, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 26, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 6, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 18, 2020 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 26, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 24, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 24, 2019 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 24, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 24, 2019 GNSL
SUSPENSION LETTER WRITTEN
Apr 24, 2019 CNSL
ASSIGNED TO EXAMINER
Apr 23, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 5, 2019 NWOS
NEW APPLICATION ENTERED
Mar 21, 2019 NWAP